Deductible Status in the Pediatric Population: A Barrier to Appropriate Care?

Vanessa F Torrecillas1, Kaden Neuberger2, Alexander Ramirez3

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA.

Insights

High-deductible health plans significantly impact pediatric tonsillectomy rates. Meeting deductibles may increase elective surgeries, while unmet high deductibles may discourage them, potentially affecting care access.

Area of Science:

  • Health Services Research
  • Pediatric Health Economics
  • Health Insurance Policy

Background:

  • High-deductible health plans (HDHPs) are increasingly common, influencing patient healthcare decisions.
  • Understanding the impact of HDHPs on elective pediatric procedures is crucial for equitable care access.

Purpose of the Study:

  • To evaluate the effect of HDHPs on the incidence of pediatric tonsillectomy.
  • To compare the impact of different deductible levels and met/unmet deductible status on elective surgery rates.

Main Methods:

  • Cross-sectional study analyzing a health claims database from 2016-2019.
  • Included 10,047 pediatric tonsillectomy cases and 9,903 nonelective arm fracture repairs.
  • Compared surgery incidence across high, low, and government-insured deductible plans, considering deductible fulfillment.

Main Results:

  • Tonsillectomy rates varied significantly by health plan deductible type.
  • Patients with met deductibles were more likely to undergo tonsillectomy, especially with high deductibles (≥$4000).
  • No similar impact was observed for nonelective arm fracture repairs, suggesting plan type influences elective procedures.

Conclusions:

  • Health insurance plan structure affects pediatric elective surgery rates like tonsillectomy.
  • Unmet high deductibles may deter necessary elective procedures, potentially leading to delayed or inappropriate care.
  • Met deductibles, particularly high ones, may correlate with increased tonsillectomy incidence, raising concerns about potential overutilization.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
72
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
74
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
71
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
90
Barriers to Effective Communication II01:21

Barriers to Effective Communication II

The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
4.3K